|
2025 Journal Article Explainable time-to-progression predictions in multiple sclerosisD’hondt, Robbe, Dedja, Klest, Aerts, Sofie, Van Wijmeersch, Bart, Kalincik, Tomas, Reddel, Stephen, Havrdova, Eva Kubala, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Mrabet, Saloua, Lalive, Patrice, Kermode, Allan G., Ozakbas, Serkan, Patti, Francesco, Prat, Alexandre, Tomassini, Valentina, Roos, Izanne, Alroughani, Raed, Gerlach, Oliver, Khoury, Samia J., van Pesch, Vincent, Sa, Maria Jose, Prevost, Julie, Spitaleri, Daniele, McCombe, Pamela, Solaro, Claudio, van der Walt, Anneke, Butzkueven, Helmut, Laureys, Guy ... Vens, Celine (2025). Explainable time-to-progression predictions in multiple sclerosis. Computer Methods and Programs in Biomedicine, 263 108624, 1-23. doi: 10.1016/j.cmpb.2025.108624 |
|
2025 Journal Article An fMRI dataset for appetite neural correlates in people living with Motor Neuron DiseaseChang, Jeryn, Lv, JingLei, Guo, Christine C., Lucia, Diana, Bollmann, Saskia, Garner, Kelly, McCombe, Pamela A., Henderson, Robert D., Shaw, Thomas B., Steyn, Frederik J. and Ngo, Shyuan T. (2025). An fMRI dataset for appetite neural correlates in people living with Motor Neuron Disease. Scientific Data, 12 (1) 466, 1-8. doi: 10.1038/s41597-025-04828-w |
|
2025 Journal Article Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cuesChang, Jeryn, Shaw, Thomas B., McCombe, Pamela A., Henderson, Robert D., Lucia, Diana, Guo, Christine C., Lv, Jinglei, Garner, Kelly, Bollmann, Saskia, Ngo, Shyuan T. and Steyn, Frederik J. (2025). Appetite loss in patients with motor neuron disease: impact on weight loss and neural correlates of visual food cues. Brain Communications, 7 (2) fcaf111, 1-14. doi: 10.1093/braincomms/fcaf111 |
|
2025 Journal Article Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosisBuckett, Lauren E., Holdom, Cory J., Howe, Stephanie L., McCombe, Pamela A., Henderson, Robert D., Al-Chalabi, Ammar, Steyn, Frederik J. and Ngo, Shyuan T. (2025). Persistent high levels of perceived fatigue are not associated with hypermetabolism in patients with amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (5-6), 485-494. doi: 10.1080/21678421.2025.2471429 |
|
2025 Journal Article First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosisToscano, Simona, Spelman, Tim, Ozakbas, Serkan, Alroughani, Raed, Chisari, Clara G., Lo Fermo, Salvatore, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Izquierdo, Guillermo, Eichau, Sara, Grammond, Pierre, Boz, Cavit, Kalincik, Tomas, Blanco, Yolanda, Buzzard, Katherine, Skibina, Olga, Sa, Maria Jose, van der Walt, Anneke, Butzkueven, Helmut, Terzi, Murat, Gerlach, Oliver, Grand'Maison, Francois, Foschi, Matteo, Surcinelli, Andrea, Barnett, Michael, Lugaresi, Alessandra, Onofrj, Marco, Yamout, Bassem ... Patti, Francesco (2025). First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis. Neurotherapeutics, 22 (2) e00552, e00552. doi: 10.1016/j.neurot.2025.e00552 |
|
2025 Journal Article Estimation of transition probabilities from a large cohort (> 6000) of Australians living with Multiple Sclerosis (MS) for changing disability severity classifications, MS phenotype, and disease-modifying therapy classificationsCampbell, Julie A., Henson, Glen J., Ngwa, Valery Fuh, Ahmad, Hasnat, Taylor, Bruce V., van der Mei, Ingrid, Ramanathan, Sudarshini, Hardy, Todd A., Shaw, Cameron, Garber, Justin, Macdonell, Richard, McCombe, Pamela, John, Nevin, Hodgkinson, Suzanne, Walt, Anneke van der, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Carroll, William M., Fabis-Pedrini, Marzena, Kermode, Allan G., Butzkueven, Helmut, Palmer, Andrew J. and MSBase Australian Researchers (2025). Estimation of transition probabilities from a large cohort (> 6000) of Australians living with Multiple Sclerosis (MS) for changing disability severity classifications, MS phenotype, and disease-modifying therapy classifications. PharmacoEconomics, 43 (2) 102247, 223-239. doi: 10.1007/s40273-024-01417-4 |
|
2025 Journal Article Investigating the frequency of neural autoantibodies in refractory focal epilepsyGillinder, Lisa, Craig, Donald, Powell, Tamara, Walsh, Stephen, Phamnguyen, John, Wilson, Ian, Chen, Xiaohua, Gillis, David and McCombe, Pamela (2025). Investigating the frequency of neural autoantibodies in refractory focal epilepsy. Seizure: European Journal of Epilepsy, 125, 73-78. doi: 10.1016/j.seizure.2025.01.007 |
|
2025 Journal Article HLA typing in anti-GAD antibody associated epilepsyGillinder, Lisa, Powell, Tamara, Craig, Donald, Walsh, Stephen, Gillis, David and McCombe, Pamela (2025). HLA typing in anti-GAD antibody associated epilepsy. Epilepsy and Behavior, 163 110179, 110179. doi: 10.1016/j.yebeh.2024.110179 |
|
2025 Journal Article Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysisNona, Robert J., Henderson, Robert D. and McCombe, Pamela A. (2025). Routine blood biochemical biomarkers in amyotrophic lateral sclerosis: Systematic review and cohort analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 26 (3-4), 1-19. doi: 10.1080/21678421.2024.2435976 |
|
2025 Journal Article Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase RegistryGomez-Figueroa, Enrique, Orozco-Puga, Patricia, Corona-Vazquez, Cynthia Patricia, Moreno-Bernardino, Carlos, Elizabeth De La Mora-landin, Graciela, Jimenez-Ruiz, Amado, Garcia-Estrada, Christian, Zertuche-Ortuno, Lizeth, Saldivar-Davila, Sergio, Rodriguez-Rivas, Roberto, Bazan-Rodriguez, Lisette, Flores-Rivera, Jose, Kalincik, Tomas, Buzzard, Katherine, Khoury, Samia, Duquette, Pierre, Foschi, Matteo, Surcinelli, Andrea, Weinstock-Guttman, Bianca, Gouider, Riadh, Mrabet, Saloua, Lechner-Scott, Jeannette, Butzkueven, Helmut, Alroughani, Raed, Roos, Izanne, Patti, Francesco, Yamout, Bassem, Grand'maison, Francois, Spitaleri, Daniele ... Ruiz-Sandoval, Jose Luis (2025). Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase Registry. Therapeutic Advances in Neurological Disorders, 18 17562864251399595. doi: 10.1177/17562864251399595 |
|
2025 Journal Article Correction to: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications (PharmacoEconomics, (2024), 10.1007/s40273-024-01417-4)Campbell, Julie A., Henson, Glen J., Ngwa, Valery Fuh, Ahmad, Hasnat, Taylor, Bruce V., van der Mei, Ingrid, Ramanathan, Sudarshini, Hardy, Todd A., Shaw, Cameron, Garber, Justin, Macdonell, Richard, McCombe, Pamela, John, Nevin, Hodgkinson, Suzanne, van der Walt, Anneke, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Carroll, William M., Fabis-Pedrini, Marzena, Kermode, Allan G., Butzkueven, Helmut and Palmer, Andrew J. (2025). Correction to: Estimation of Transition Probabilities from a Large Cohort (> 6000) of Australians Living with Multiple Sclerosis (MS) for Changing Disability Severity Classifications, MS Phenotype, and Disease-Modifying Therapy Classifications (PharmacoEconomics, (2024), 10.1007/s40273-024-01417-4). PharmacoEconomics, 43 (2), 241-241. doi: 10.1007/s40273-024-01461-0 |
|
2025 Journal Article Persistent progression independent of relapse activity in multiple sclerosisZhu, Chao, Zhou, Zhen, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Alroughani, Raed, Kuhle, Jens, Girard, Marc, Grammond, Pierre, Lechner-Scott, Jeannette, Gerlach, Oliver, John, Nevin, Mccombe, Pamela, Macdonell, Richard, Van Pesch, Vincent, Laureys, Guy, Prevost, Julie, Horakova, Dana, Kubala Havrdova, Eva, Castillo-Triviño, Tamara, Ramo-Tello, Cristina, Blanco, Yolanda, Meca-Lallana, Jose E, Lugaresi, Alessandra, Tomassini, Valentina, Cartechini, Elisabetta, Amato, Maria Pia, Spitaleri, Daniele ... Butzkueven, Helmut (2025). Persistent progression independent of relapse activity in multiple sclerosis. Brain Communications, 7 (5) fcaf306, 5. doi: 10.1093/braincomms/fcaf306 |
|
2025 Journal Article Amyotrophic lateral sclerosis established as a multistep process across phenotypesZiser, Laura, van Eijk, Ruben P. A., Kiernan, Matthew C., McRae, Allan, Henderson, Robert D., Schultz, David, Needham, Merrilee, Mathers, Susan, McCombe, Pam, Talman, Paul and Vucic, Steve (2025). Amyotrophic lateral sclerosis established as a multistep process across phenotypes. European Journal of Neurology, 32 (1) e16532, e16532. doi: 10.1111/ene.16532 |
|
2025 Journal Article Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay in Two Half-SiblingsYeow, Dennis, Katz, Matthew, Rodgers, Jonathan, Davis, Mark, Robertson, Thomas, Gardner, R. J. McKinlay and McCombe, Pamela A. (2025). Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay in Two Half-Siblings. Annals of Clinical and Translational Neurology, 13 (2) acn3.70236, 413-417. doi: 10.1002/acn3.70236 |
|
2024 Journal Article Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSDSiriratnam, Pakeeran, Huda, Saif, Van Der Walt, Anneke, Sanfilippo, Paul G., Sharmin, Sifat, Foong, Yi Chao, Yeh, Wei Z., Zhu, Chao, Khoury, Samia J., Csepany, Tunde, Willekens, Barbara, Etemadifar, Masoud, Ozakbas, Serkan, Nytrova, Petra, Altintas, Ayse, Al-Asmi, Abdullah, Ramo-Tello, Cristina M., Laureys, Guy, Patti, Francesco, Horakova, Dana, Foschi, Matteo, Boz, Cavit, McCombe, Pamela A., Turkoglu, Recai, Lechner-Scott, Jeannette, Roos, Izanne, Kalincik, Tomas, Jokubaitis, Vilija G., Butzkueven, Helmut ... for MSBase (2024). Prevalence of progression independent of relapse activity and relapse-associated worsening in patients with AQP4-IgG–positive NMOSD. Neurology, 103 (12) e209940, 1-8. doi: 10.1212/wnl.0000000000209940 |
|
2024 Journal Article Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry studyKreiter, Daniel, Kalincik, Tomas, Hupperts, Raymond, Patti, Francesco, Spitaleri, Daniele, Foschi, Matteo, Surcinelli, Andrea, Maimone, Davide, Yamout, Bassem, Khoury, Samia J., Lechner-Scott, Jeannette, Ozakbas, Serkan, Gerlach, Oliver, Turkoglu, R., Soysal, A., Boz, C., Al-Asmi, A., Alkhaboori, J., Amato, M. P., Onofrj, M., Lugaresi, A., Besora, S., Sanchez-Menoyo, J. L., Lapointe, E., Grand’Maison, F., Grammond, P., Butzkueven, H., Van der Walt, A., Taylor, B. V. ... Barnett, M. H. (2024). Effectiveness of disease-modifying treatment on spinal cord lesion formation in relapse-onset multiple sclerosis: an MSBase registry study. CNS Drugs, 38 (11), 921-930. doi: 10.1007/s40263-024-01115-x |
|
2024 Conference Publication DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosisMaltby, Vicki E., Xavier, Alexandre, Monif, Mastura, Min, Myintzu, Fabis-Pedrini, Marzena J., Buzzard, Katherine, Kalincik, Tomas, Kermode, Allan G., Taylor, Bruce, Hodgkinson, Suzanne, McCombe, Pamela, Osborne, Meaghan, Butzkueven, Helmut, Barnett, Michael, Lea, Rodney A. and Lechner-Scott, Jeannette (2024). DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapiesYeh, Wei Z., Van Der Walt, Anneke, Skibina, Olga G., Kalincik, Tomas, Alroughani, Raed, Kermode, Allan G., Fabis-Pedrini, Marzena J., Carroll, William M., Lechner-Scott, Jeannette, Boz, Cavit, Ozakbas, Serkan, Buzzard, Katherine, Habek, Mario, John, Nevin A., Prat, Alexandre, Girard, Marc, Duquette, Pierre, Baghbanian, Seyed Mohammad, Hodgkinson, Suzanne, Van Pesch, Vincent, Laureys, Guy, Willekens, Barbara, Prevost, Julie, Foschi, Matteo, De Gans, Koen, Horakova, Dana, Havrdova, Eva Kubala, Karabudak, Rana, Patti, Francesco ... for the MSBase Study Group (2024). Disease activity in pregnant and postpartum women with multiple sclerosis receiving ocrelizumab or other disease-modifying therapies. Neurology Neuroimmunology and Neuroinflammation, 11 (6) e200328, 1-16. doi: 10.1212/nxi.0000000000200328 |
|
2024 Conference Publication The risk of secondary progressive multiple sclerosis is geographically determined but modifiableSharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Kermode, Allan, Butler, Ernest, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Taylor, Bruce, Slee, Mark, Macdonell, Richard, Garber, Justin, Shaw, Cameron, Shuey, Neil, Massey, Jennifer, Hardy, Todd, Parratt, John and Kalincik, Tomas (2024). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications. |
|
2024 Journal Article Assessing the effect of Riluzole on motor unit discharge propertiesShandiz, Ehsan, Fernandes, Gabriel Lima, Henkin, Joao Saldanha, McCombe, Pamela Ann, Trajano, Gabriel Siqueira and Henderson, Robert David (2024). Assessing the effect of Riluzole on motor unit discharge properties. Brain Sciences, 14 (11) 1053, 1053. doi: 10.3390/brainsci14111053 |
